Anti-CD11b antibody [EP1345Y] - C-terminal (Ab52478)
CD11b, CD11B, CR3A, ITGAM, Integrin alpha-M, CD11 antigen-like family member B, CR-3 alpha chain, Cell surface glycoprotein MAC-1 subunit alpha, Leukocyte adhesion receptor MO1, Neutrophil adherence receptor
详细信息
特异性
Testing of mouse and rat tissues (brain, spleen, kidney and heart) in WB gave negative results. However, flow cytometry for mouse RAW 264.7 cell line gave positive results. We have not tested any rat samples in flow cytometry. Due to the variability in mouse, we do not list this as a tested species. We welcome any feedback on mouse and rat reactivity.
背景信息
What is this antibody validated in? Anti-CD11b antibody [EP1345Y] - C-terminal (ab52478) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of CD11b? Anti-CD11b [EP1345Y] - C-terminal (ab52478) specifically detects a band for CD11b (UniProt: P11215) at a molecular weight of 128kDa. Trusted by the scientific community Anti-CD11b [EP1345Y] - C-terminal (ab52478) was first used in a scientific publication in 2007 and has been cited over 70 times in peer-reviewed journals. Reviewed by scientists Anti-CD11b [EP1345Y] - C-terminal (ab52478) has over 5 independent reviews from customers. Other related products We have a range of other formats of antibody clone [EP1345Y] also available for your convenience: ab52478, Carrier free - ab187537, PE - ab213186, APC - ab221248, Oligonucleotide - ab284435 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (70)
A novel organoid model retaining the glioma microenvironment for personalized drug screening and therapeutic evaluation
一种新型类器官模型,保留了胶质瘤微环境,可用于个性化药物筛选和治疗评估。
Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs
肠道微生物代谢产物4-羟基苯乙酸通过免疫抑制性PMN-MDSC的积累驱动结直肠癌进展
Targeting mitochondrial complex I of CD177+ neutrophils alleviates lung ischemia-reperfusion injury
靶向CD177+中性粒细胞的线粒体复合物I可减轻肺缺血再灌注损伤。
MAFF alleviates hepatic ischemia-reperfusion injury by regulating the CLCF1/STAT3 signaling pathway
MAFF通过调节CLCF1/STAT3信号通路减轻肝脏缺血再灌注损伤
Advanced Lung-on-a-Chip Technology: Mimicking the Complex Human Lung Microenvironment
先进的肺芯片技术:模拟复杂的人类肺微环境
Differential Immune Cell Infiltration in Eosinophilic and Non-Eosinophilic CRS: Correlations With Clinical, Endoscopic, and Radiological Findings.
嗜酸性粒细胞性和非嗜酸性粒细胞性 CRS 中免疫细胞浸润的差异:与临床、内镜和放射学结果的相关性
Piezo1 Enhances Macrophage Phagocytosis and Pyrin Activation to Ameliorate Fungal Keratitis
Piezo1 增强巨噬细胞吞噬作用和 Pyrin 活化,从而改善真菌性角膜炎
Sex-determining region Y-Box 4 promotes the progression of advanced hepatocellular carcinoma and enhances regulatory T-cell infiltration and immune suppression.
性别决定区 Y-Box 4 促进晚期肝细胞癌的进展,增强调节性 T 细胞浸润和免疫抑制
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities
微环境塑造小细胞肺癌神经内分泌状态并提供治疗机会
Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma
MerTK的破坏可通过增强铁死亡和免疫反应来提高肝细胞癌中检查点抑制剂的疗效。
- 1
- 2
- 3
- 4
- 5
- 6
- 7